Prokidney (PROK) Research & Development (2021 - 2026)

Prokidney (PROK) has 6 years of Research & Development data on file, last reported at $33.8 million in Q1 2026.

• On a quarterly basis, Research & Development rose 24.13% year-over-year to $33.8 million in Q1 2026; TTM through Mar 2026 was $120.7 million, a 5.48% decrease from a year earlier, with the FY2025 full-year figure at $114.1 million, down 10.61% from the prior year.
• Research & Development for Q1 2026 stood at $33.8 million, down from $34.2 million in the prior quarter.
• Over the last five years, Research & Development for PROK reached as high as $39.8 million in Q4 2024 and fell as low as $11.6 million in Q2 2022.
• Historically, Research & Development has averaged $27.3 million across 5 years, with a median of $27.2 million in 2024.
• Across the five-year window, Research & Development jumped 128.1% in 2023 and retreated 14.17% in 2025, its largest moves.
• Year by year, Research & Development stood at $20.9 million in 2022, then climbed by 7.84% to $22.5 million in 2023, then surged by 76.58% to $39.8 million in 2024, then retreated by 14.14% to $34.2 million in 2025, then dropped by 0.92% to $33.8 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $33.8 million in Q1 2026, $34.2 million in Q4 2025, and $26.8 million in Q3 2025.